Compare $MPLT vs $PROK | Chartloom

Compare

$MPLT vs $PROK

MapLight Therapeutics Inc · Prokidney Corp

MPLT

MapLight Therapeutics Inc

PROK

Prokidney Corp

Compare $MPLT vs $PROK

Comparing MapLight Therapeutics Inc and Prokidney Corp

MPLTMapLight Therapeutics Inc

PROKProkidney Corp

MPLTMapLight Therapeutics Inc

Market cap

$400M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-47.3%

52W performance

-51.9%

FCF yield

-43.7%

PROKProkidney Corp

Market cap

$526M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

788.85x

Rev growth (TTM)

55.2%

YTD performance

-22.0%

52W performance

-46.6%

FCF yield

-30.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

MPLT

PROK

Detailed metrics comparison

MPLT

MapLight Therapeutics Inc

PROK

Prokidney Corp

Market Cap

MPLT$400M

PROK$526M

Enterprise Value

MPLT$329M

PROK$451M

Price

MPLT$8.83

PROK$1.74

P/E Ratio

MPLTN/A

PROKN/A

P/S Ratio

MPLT0.00x

PROK642.52x

EV/Sales

MPLT0.00x

PROK551.08x

EV/EBITDA

MPLT0.00x

PROK0.00x

P/B Ratio

MPLT1.57x

PROK78.79x

P/FCF Ratio

MPLTN/A

PROKN/A

EV/FCF

MPLT-1.88x

PROK-2.82x

PEG Ratio

MPLTN/A

PROKN/A

Forward P/E (NTM)

MPLTN/A

PROKN/A

Forward P/S (NTM)

MPLTN/A

PROK788.85x

Revenue (TTM)

MPLT$0

PROK$818K

Revenue Growth (YoY)

MPLTN/A

PROK55.2%

Forward Rev Growth

MPLT949.5%

PROK-44.4%

Gross Margin (TTM)

MPLT0.0%

PROK0.0%

Operating Margin (TTM)

MPLT0.0%

PROK0.0%

EBITDA Margin (TTM)

MPLT0.0%

PROK-20827.6%

Net Margin (TTM)

MPLT0.0%

PROK-10288.4%

FCF Margin (TTM)

MPLTN/A

PROK-19527.4%

Net Income (TTM)

MPLT$-230M

PROK$-84M

FCF (TTM)

MPLT$-175M

PROK$-160M

EPS (TTM)

MPLT-$5.06

PROK-$0.45

ROE (TTM)

MPLT-6384.0%

PROK-2810.2%

ROA (TTM)

MPLT-6033.0%

PROK-2739.0%

ROIC (TTM)

MPLT-6384.0%

PROK0.0%

Cash

MPLT$72M

PROK$75M

Debt

MPLT$0

PROK$67K

Net Cash/Debt

MPLT$72M

PROK$75M

Current Ratio (TTM)

MPLT16.52x

PROK8.36x

Quick Ratio (TTM)

MPLT15.79x

PROK8.07x

Debt/Equity (TTM)

MPLT0.00x

PROK5.40x

Debt/Assets (TTM)

MPLT0.0%

PROK0.0%

Interest Coverage (TTM)

MPLTN/A

PROKN/A

Net Debt/EBITDA (TTM)

MPLT0.00x

PROK0.00x

Beta

MPLT0.85

PROK1.95

52W Performance

MPLT-51.9%

PROK-46.6%

YTD Performance

MPLT-47.3%

PROK-22.0%

% from 52W High

MPLT-78.2%

PROK-50.0%

% from 52W Low

MPLT1.5%

PROK33.8%

Asset Turnover (TTM)

MPLT0.00x

PROK0.00x

FCF Yield (TTM)

MPLT-43.7%

PROK-30.4%

Earnings Yield (TTM)

MPLT-57.4%

PROK-16.0%

Dividend Yield (TTM)

MPLTN/A

PROKN/A

Rule of 40

MPLT0.0

PROK-19,472.2

EV/GP/RG

MPLTN/A

PROKN/A

Ticker research

View MPLT research View PROK research

Metric	MPLT MapLight Therapeutics Inc	PROK Prokidney Corp
Market & Valuation
Market Cap	$400M	$526M
Enterprise Value	$329M	$451M
Price	$8.83	$1.74
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	642.52x
EV/Sales	0.00x	551.08x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.57x	78.79x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.88x	-2.82x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	788.85x
Revenue & Growth
Revenue (TTM)	$0	$818K
Revenue Growth (YoY)	N/A	55.2%
Forward Rev Growth	949.5%	-44.4%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-20827.6%
Net Margin (TTM)	0.0%	-10288.4%
FCF Margin (TTM)	N/A	-19527.4%
Net Income (TTM)	$-230M	$-84M
FCF (TTM)	$-175M	$-160M
EPS (TTM)	-$5.06	-$0.45
ROE (TTM)	-6384.0%	-2810.2%
ROA (TTM)	-6033.0%	-2739.0%
ROIC (TTM)	-6384.0%	0.0%
Financial Health
Cash	$72M	$75M
Debt	$0	$67K
Net Cash/Debt	$72M	$75M
Current Ratio (TTM)	16.52x	8.36x
Quick Ratio (TTM)	15.79x	8.07x
Debt/Equity (TTM)	0.00x	5.40x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.85	1.95
52W Performance	-51.9%	-46.6%
YTD Performance	-47.3%	-22.0%
% from 52W High	-78.2%	-50.0%
% from 52W Low	1.5%	33.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-43.7%	-30.4%
Earnings Yield (TTM)	-57.4%	-16.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-19,472.2
EV/GP/RG	N/A	N/A
Ticker research	View MPLT research	View PROK research

Valuation

P/S Ratio

MPLT

0.00x

PROK

642.52x

EV/FCF

PROK

-2.82x

MPLT

-1.88x

Growth & revenue

Revenue Growth TTM

PROK

55.2%

Forward Revenue Growth

MPLT

949.5%

PROK

-44.4%

Profitability & performance

Gross Margin

MPLT

0.0%

PROK

0.0%

ROE

PROK

-2810.2%

MPLT

-6384.0%

FCF Yield %

PROK

-30.4%

MPLT

-43.7%

52-Week Performance

PROK

-46.6%

MPLT

-51.9%

Detailed metrics comparison

MPLT

MapLight Therapeutics Inc

PROK

Prokidney Corp

Market Cap

MPLT$400M

PROK$526M

Enterprise Value

MPLT$329M

PROK$451M

Price

MPLT$8.83

PROK$1.74

P/E Ratio

MPLTN/A

PROKN/A

P/S Ratio

MPLT0.00x

PROK642.52x

EV/Sales

MPLT0.00x

PROK551.08x

EV/EBITDA

MPLT0.00x

PROK0.00x

P/B Ratio

MPLT1.57x

PROK78.79x

P/FCF Ratio

MPLTN/A

PROKN/A

EV/FCF

MPLT-1.88x

PROK-2.82x

PEG Ratio

MPLTN/A

PROKN/A

Forward P/E (NTM)

MPLTN/A

PROKN/A

Forward P/S (NTM)

MPLTN/A

PROK788.85x

Revenue (TTM)

MPLT$0

PROK$818K

Revenue Growth (YoY)

MPLTN/A

PROK55.2%

Forward Rev Growth

MPLT949.5%

PROK-44.4%

Gross Margin (TTM)

MPLT0.0%

PROK0.0%

Operating Margin (TTM)

MPLT0.0%

PROK0.0%

EBITDA Margin (TTM)

MPLT0.0%

PROK-20827.6%

Net Margin (TTM)

MPLT0.0%

PROK-10288.4%

FCF Margin (TTM)

MPLTN/A

PROK-19527.4%

Net Income (TTM)

MPLT$-230M

PROK$-84M

FCF (TTM)

MPLT$-175M

PROK$-160M

EPS (TTM)

MPLT-$5.06

PROK-$0.45

ROE (TTM)

MPLT-6384.0%

PROK-2810.2%

ROA (TTM)

MPLT-6033.0%

PROK-2739.0%

ROIC (TTM)

MPLT-6384.0%

PROK0.0%

Cash

MPLT$72M

PROK$75M

Debt

MPLT$0

PROK$67K

Net Cash/Debt

MPLT$72M

PROK$75M

Current Ratio (TTM)

MPLT16.52x

PROK8.36x

Quick Ratio (TTM)

MPLT15.79x

PROK8.07x

Debt/Equity (TTM)

MPLT0.00x

PROK5.40x

Debt/Assets (TTM)

MPLT0.0%

PROK0.0%

Interest Coverage (TTM)

MPLTN/A

PROKN/A

Net Debt/EBITDA (TTM)

MPLT0.00x

PROK0.00x

Beta

MPLT0.85

PROK1.95

52W Performance

MPLT-51.9%

PROK-46.6%

YTD Performance

MPLT-47.3%

PROK-22.0%

% from 52W High

MPLT-78.2%

PROK-50.0%

% from 52W Low

MPLT1.5%

PROK33.8%

Asset Turnover (TTM)

MPLT0.00x

PROK0.00x

FCF Yield (TTM)

MPLT-43.7%

PROK-30.4%

Earnings Yield (TTM)

MPLT-57.4%

PROK-16.0%

Dividend Yield (TTM)

MPLTN/A

PROKN/A

Rule of 40

MPLT0.0

PROK-19,472.2

EV/GP/RG

MPLTN/A

PROKN/A

Ticker research

View MPLT research View PROK research

Metric	MPLT MapLight Therapeutics Inc	PROK Prokidney Corp
Market & Valuation
Market Cap	$400M	$526M
Enterprise Value	$329M	$451M
Price	$8.83	$1.74
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	642.52x
EV/Sales	0.00x	551.08x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.57x	78.79x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.88x	-2.82x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	788.85x
Revenue & Growth
Revenue (TTM)	$0	$818K
Revenue Growth (YoY)	N/A	55.2%
Forward Rev Growth	949.5%	-44.4%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-20827.6%
Net Margin (TTM)	0.0%	-10288.4%
FCF Margin (TTM)	N/A	-19527.4%
Net Income (TTM)	$-230M	$-84M
FCF (TTM)	$-175M	$-160M
EPS (TTM)	-$5.06	-$0.45
ROE (TTM)	-6384.0%	-2810.2%
ROA (TTM)	-6033.0%	-2739.0%
ROIC (TTM)	-6384.0%	0.0%
Financial Health
Cash	$72M	$75M
Debt	$0	$67K
Net Cash/Debt	$72M	$75M
Current Ratio (TTM)	16.52x	8.36x
Quick Ratio (TTM)	15.79x	8.07x
Debt/Equity (TTM)	0.00x	5.40x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.85	1.95
52W Performance	-51.9%	-46.6%
YTD Performance	-47.3%	-22.0%
% from 52W High	-78.2%	-50.0%
% from 52W Low	1.5%	33.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-43.7%	-30.4%
Earnings Yield (TTM)	-57.4%	-16.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-19,472.2
EV/GP/RG	N/A	N/A
Ticker research	View MPLT research	View PROK research